{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:10:31Z","timestamp":1739999431160,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,19]]},"DOI":"10.7759\/cureus.79315","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:36:16Z","timestamp":1739997376000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Severe Prekallikrein Deficiency Manifesting as Isolated Activated Partial Thromboplastin Time (aPTT) Prolongation"],"prefix":"10.7759","author":[{"given":"Divya","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abiram","family":"Sivanandam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211012187","article-title":"A rare cause of isolated prolonged activated partial thromboplastin time: an overview of prekallikrein deficiency and the contact system","volume":"9","author":"Riano I","year":"2021","unstructured":"Riano I, Prasongdee K. A rare cause of isolated prolonged activated partial thromboplastin time: an overview of prekallikrein deficiency and the contact system. J Investig Med High Impact Case Rep. 2021, 9:23247096211012187. 10.1177\/23247096211012187","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14805","article-title":"Severe plasma prekallikrein deficiency: clinical characteristics, novel KLKB1 mutations, and estimated prevalence","volume":"18","author":"Barco S","year":"2020","unstructured":"Barco S, Sollfrank S, Trinchero A, et al.. Severe plasma prekallikrein deficiency: clinical characteristics, novel KLKB1 mutations, and estimated prevalence. J Thromb Haemost. 2020, 18:1598-617. 10.1111\/jth.14805","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801028-0.00181-1","article-title":"Subchapter 30B - kallikrein","author":"Wong MK","year":"2016","unstructured":"Wong MK. Subchapter 30B - kallikrein. Handbook of Hormones. Takei Y, Ando H, Tsutsui K (ed): Academic Press, Washington D.C.; 2016. 271-3. 10.1016\/B978-0-12-801028-0.00181-1"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36617","article-title":"The elusive physiologic role of Factor XII","volume":"118","author":"Schmaier AH","year":"2008","unstructured":"Schmaier AH. The elusive physiologic role of Factor XII. J Clin Invest. 2008, 118:3006-9. 10.1172\/JCI36617","journal-title":"J Clin Invest"},{"key":"ref5","article-title":"Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis","volume":"252","author":"Mandle R Jr","year":"1977","unstructured":"Mandle R Jr, Kaplan AP. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977, 252:6097-104.","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.1.28","article-title":"Plasmin-mediated activation of contact system in response to pharmacological thrombolysis","volume":"91","author":"Ewald GA","year":"1995","unstructured":"Ewald GA, Eisenberg PR. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation. 1995, 91:28-36. 10.1161\/01.cir.91.1.28","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2020.41.190005","article-title":"Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: a systematic literature review of case reports","volume":"41","author":"Girolami A","year":"2020","unstructured":"Girolami A, Rolland C, Sexton D, Vardi M, Bernstein JA. Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: a systematic literature review of case reports. Allergy Asthma Proc. 2020, 41:10-8. 10.2500\/aap.2020.41.190005","journal-title":"Allergy Asthma Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/723204","article-title":"Prekallikrein deficiency presenting as recurrent cerebrovascular accident: case report and review of the literature","volume":"2012","author":"Bojanini EU","year":"2012","unstructured":"Bojanini EU, Loaiza-Bonilla A, Pimentel A. Prekallikrein deficiency presenting as recurrent cerebrovascular accident: case report and review of the literature. Case Rep Hematol. 2012, 2012:723204. 10.1155\/2012\/723204","journal-title":"Case Rep Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3181b270bb","article-title":"A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage","volume":"338","author":"Dasanu CA","year":"2009","unstructured":"Dasanu CA, Alexandrescu DT. A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage. Am J Med Sci. 2009, 338:429-30. 10.1097\/MAJ.0b013e3181b270bb","journal-title":"Am J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4054806","article-title":"Clinical scenarios for discordant anti-Xa","volume":"2016","author":"Vera-Aguilera J","year":"2016","unstructured":"Vera-Aguilera J, Yousef H, Beltran-Melgarejo D, et al.. Clinical scenarios for discordant anti-Xa. Adv Hematol. 2016, 2016:4054806. 10.1155\/2016\/4054806","journal-title":"Adv Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198307000-00004","article-title":"Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases","volume":"62","author":"Goodnough LT","year":"1983","unstructured":"Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore). 1983, 62:248-55. 10.1097\/00005792-198307000-00004","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000313361","article-title":"Thrombotic events in patients with congenital prekallikrein deficiency: a critical evaluation of all reported cases","volume":"123","author":"Girolami A","year":"2010","unstructured":"Girolami A, Allemand E, Bertozzi I, Candeo N, Marun S, Girolami B. Thrombotic events in patients with congenital prekallikrein deficiency: a critical evaluation of all reported cases. Acta Haematol. 2010, 123:210-4. 10.1159\/000313361","journal-title":"Acta Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2016.02.020","article-title":"A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation","volume":"140","author":"Kokoye Y","year":"2016","unstructured":"Kokoye Y, Ivanov I, Cheng Q, et al.. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation. Thromb Res. 2016, 140:118-24. 10.1016\/j.thromres.2016.02.020","journal-title":"Thromb Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343119-a-case-of-severe-prekallikrein-deficiency-manifesting-as-isolated-activated-partial-thromboplastin-time-aptt-prolongation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:36:17Z","timestamp":1739997377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343119-a-case-of-severe-prekallikrein-deficiency-manifesting-as-isolated-activated-partial-thromboplastin-time-aptt-prolongation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.79315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}